7 November 2019 - Deborah Wilkes
Archived
Worldwide sales at GlaxoSmithKline's (GSK's) Consumer Healthcare business increased by 25% at constant exchange rates in the third quarter of 2019, following consolidation of Pfizer’s Consumer Healthcare products.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.